Vismodegib as Novel Treatment of Periocular Basal Cell Carcinoma: A Mini Review

Vismodegib as Novel Treatment of Periocular Basal Cell Carcinoma: A Mini Review

Basal cell carcinoma (BCC) is the most common cancer in the world. This study aims to review vismodegib treatment in BCC patients. Vismodegib has been approved for the treatment of adults with mBCC, or with laBCC that has recurred after surgery or who are not eligible for surgical procedure nor radi...

Full description

Saved in:
Bibliographic Details
Main Author: Hendrian Dwikoloso Soebagjo
Format: Article PeerReviewed
Language:English
English
English
Published: Medknow Publications and Media Pvt. Ltd 2020
Subjects:
R Medicine (General)
RE Ophthalmology
Online Access:http://repository.unair.ac.id/95203/1/Vismodegib%20as%20Novel%20Treatment%20of%20periocular%20Basal%20cell%20Carcinoma%20A%20Mini%20Review.pdf
http://repository.unair.ac.id/95203/2/Vismodegib.pdf
http://repository.unair.ac.id/95203/3/Vismodegib%20as%20Novel%20Treatment%20of%20periocular%20Basal%20cell%20Carcinoma%20A%20Mini%20Review.pdf
http://repository.unair.ac.id/95203/
http://www.sysrevpharm.org//?mno=96004
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
English

Internet

http://repository.unair.ac.id/95203/1/Vismodegib%20as%20Novel%20Treatment%20of%20periocular%20Basal%20cell%20Carcinoma%20A%20Mini%20Review.pdf
http://repository.unair.ac.id/95203/2/Vismodegib.pdf
http://repository.unair.ac.id/95203/3/Vismodegib%20as%20Novel%20Treatment%20of%20periocular%20Basal%20cell%20Carcinoma%20A%20Mini%20Review.pdf
http://repository.unair.ac.id/95203/
http://www.sysrevpharm.org//?mno=96004

Similar Items